A multicenter team of researchers report that in a phase III clinical trial, a combination drug therapy cures chronic hepatitis C in the majority of patients co-infected with both HIV and hepatitis C.
(Medical Xpress)—HIV-infected people carry many different HIV viruses and all have distinct personalities—some much more vengeful and infectious than others.
Antibodies and their derivatives can protect plants and animals—including humans—against viruses. Members of this class of drugs are usually highly specific against components of a particular virus, and ...
Research led by the University of Adelaide has provided new insights into how the HIV virus greatly boosts its chances of spreading infection, and why HIV is so hard to combat.